5

恒瑞医药：子公司阿得贝利单抗注射液获得药品注册证书

 1 year ago
source link: https://cn.technode.com/post/2023-03-06/hengrui-adebeili/
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
neoserver,ios ssh client

恒瑞医药：子公司阿得贝利单抗注射液获得药品注册证书

2023/03/06 11:06

恒瑞医药(600276)3月5日晚间公告，子公司阿得贝利单抗注射液获得药品注册证书。

阿得贝利单抗是公司自主研发的人源化抗PD-L1单克隆抗体，能通过特异性结合PD-L1分子从而阻断导致肿瘤免疫耐受的PD-1/PD-L1通路，重新激活免疫系统的抗肿瘤活性，从而达到治疗肿瘤的目的。

来源：证券时报


report

Recommend

About Joyk


Aggregate valuable and interesting links.
Joyk means Joy of geeK